CD276 and neoplasm: In addition, pharmacodynamics studies results suggested that higher amounts of Dox were delivered to tumor sites when anti-B7H3 scFv modified pH-sensitive gold nanocage conjugates were used, suggesting that higher accumulation and sustained, controlled release in the tumor will have improved therapeutic efficacy with fewer side effects [37].